<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml</title><link>https://www.medscape.com/cx/rssfeeds/2700.xml</link><description>Individual feed output.</description><lastBuildDate>Wed, 10 Dec 2025 11:02:06 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Semaglutide Tied to 50% Lower Risk for Epilepsy in Diabetes</title><link>https://www.medscape.com/viewarticle/semaglutide-tied-50-lower-risk-epilepsy-diabetes-2025a1000ynf?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>The GLP-1 RA, semaglutide, significantly reduces epilepsy risk in diabetes, and this protective signal is driven by pathways unrelated to improvements...</description><pubDate>Wed, 10 Dec 2025 13:18:38 GMT</pubDate></item><item><title>Carfilzomib Improves Upon Bortezomib for Multiple Myeloma</title><link>https://www.medscape.com/viewarticle/carfilzomib-improves-upon-bortezomib-multiple-myeloma-2025a1000yn9?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>In the phase 3 COBRA trial, the carfilzomib/lenalidomide/dexamethasone regimen shows significant improvements in PFS and other outcomes in newly diagn...</description><pubDate>Wed, 10 Dec 2025 12:41:19 GMT</pubDate></item><item><title>Chemo-Free TKI Plus Immunotherapy Improves PH-Positive ALL</title><link>https://www.medscape.com/viewarticle/chemo-free-tki-plus-immunotherapy-improves-ph-positive-all-2025a1000yn5?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>The regimen of ponatinib combined with blinatumomab boosts outcomes vs TKI plus chemotherapy. Medscape Medical News</description><pubDate>Wed, 10 Dec 2025 12:26:18 GMT</pubDate></item><item><title>UK Medicine Rebate Rate to Drop in 2026 After US Pharma Deal</title><link>https://www.medscape.com/s/viewarticle/uk-medicine-rebate-rate-drop-2026-after-us-pharma-deal-2025a1000ynj?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>The British government said on Wednesday that the proportion of revenues from new medicine sales pharmaceutical firms need to pay back into England's ...</description><pubDate>Wed, 10 Dec 2025 12:03:59 GMT</pubDate></item><item><title>Dual Therapy Shows Promise in Chronic Migraine Prevention</title><link>https://www.medscape.com/viewarticle/onabotulinumtoxina-plus-atogepant-shows-promise-chronic-2025a1000yac?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png</image_url><description>In patients with chronic migraine, adding atogepant to onabotulinumtoxinA significantly reduces the burden of migraine, achieving a â‰¥ 50% response wit...</description><pubDate>Wed, 10 Dec 2025 12:00:00 GMT</pubDate></item></channel></rss>